NM_024675.4(PALB2):c.3086C>T (p.Thr1029Ile) AND Hereditary cancer-predisposing syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Dec 6, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003160502.2

Allele description [Variation Report for NM_024675.4(PALB2):c.3086C>T (p.Thr1029Ile)]

NM_024675.4(PALB2):c.3086C>T (p.Thr1029Ile)

Gene:

PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p12.2

Genomic location:

Preferred name:

NM_024675.4(PALB2):c.3086C>T (p.Thr1029Ile)

HGVS:

NC_000016.10:g.23621389G>A
NG_007406.1:g.24969C>T
NM_024675.4:c.3086C>TMANE SELECT
NP_078951.2:p.Thr1029Ile
LRG_308t1:c.3086C>T
LRG_308:g.24969C>T
NC_000016.9:g.23632710G>A
NM_024675.3:c.3086C>T

Protein change:

T1029I

Links:

dbSNP: rs1966768882

NCBI 1000 Genomes Browser:

rs1966768882

Molecular consequence:

NM_024675.4:c.3086C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Hereditary cancer-predisposing syndrome
Synonyms:: Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Mus musculus BCL2-associated athanogene 6 (Bag6), transcript variant 3, mRNA
Mus musculus BCL2-associated athanogene 6 (Bag6), transcript variant 3, mRNA
gi|357197138|ref|NM_001252469.1|

Nucleotide
Chain E, Capsid protein VP2
Chain E, Capsid protein VP2
gi|1890522914|pdb|5US9|E

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003867666	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Dec 6, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003867666

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Dec 6, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003867666.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.T1029I variant (also known as c.3086C>T), located in coding exon 10 of the PALB2 gene, results from a C to T substitution at nucleotide position 3086. The threonine at codon 1029 is replaced by isoleucine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine